Ellipsis Health

Ellipsis Health is an AI healthcare company based in San Francisco, California, founded in 2017 by CEO Mainul Mondal.

The company focuses on transforming mental health screening and care management by using voice analysis as a clinical-grade biomarker to detect stress, anxiety, and depression. Their mission is to prioritize mental health alongside physical health by establishing a vital sign for mental health through innovative technology. The flagship product, Sage, is an AI Care Manager that autonomously conducts patient calls, manages program enrollment, and provides clinical support. It generates clinical-grade assessments of anxiety, depression, and stress from speech in under 60 seconds. Ellipsis Health serves various stakeholders in the healthcare ecosystem, including health plans, hospitals, specialty care organizations, and employers, helping them improve patient engagement and outcomes. The company has raised $75 million in funding from prominent investors, including Salesforce and CVS Health, and is recognized for its pioneering work in AI-powered mental health solutions.